Your search returned 3 results.

Results
	1.	Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma. [electronic resource] by Courtney, Kevin D Infante, Jeffrey R Lam, Elaine T Figlin, Robert A Rini, Brian I Brugarolas, James Zojwalla, Naseem J Lowe, Ann M Wang, Keshi Wallace, Eli M Josey, John A Choueiri, Toni K Producer: 20190802 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. [electronic resource] by Harmatz, Paul Giugliani, Roberto Schwartz, Ida Guffon, Nathalie Teles, Elisa Leão Miranda, M Clara Sá Wraith, J Edmond Beck, Michael Arash, Laila Scarpa, Maurizio Yu, Zi-Fan Wittes, Janet Berger, Kenneth I Newman, Mary S Lowe, Ann M Kakkis, Emil Swiedler, Stuart J Producer: 20060613 In: The Journal of pediatrics vol. 148 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. [electronic resource] by Friedberg, Jonathan W Sharman, Jeff Sweetenham, John Johnston, Patrick B Vose, Julie M Lacasce, Ann Schaefer-Cutillo, Julia De Vos, Sven Sinha, Rajni Leonard, John P Cripe, Larry D Gregory, Stephanie A Sterba, Michael P Lowe, Ann M Levy, Ronald Shipp, Margaret A Producer: 20100503 In: Blood vol. 115 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)